Trials / Sponsors / Kosei Hasegawa, MD, PhD
Kosei Hasegawa, MD, PhD
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurre Carcinoma, Ovarian Epithelial | Phase 2 | 2022-04-20 |